Efficacy of donepezil on secondary end points in a randomized, double-blind placebo-controlled study in severe Alzheimer's disease

被引:0
|
作者
Eriksson, S
Winblad, B
Kilander, L
Batsman, S
Jansson-Blixt, C
Wetterholm, AL
Haglund, A
Minthon, L
机构
[1] Umea Univ, Umea, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[4] Kalix Vardcent, Dept Primary Care, Kalix, Sweden
[5] Pfizer Biostat, Taby, Sweden
[6] Pfizer Neurosci, Taby, Sweden
[7] Univ Hosp MAS, Neuropsychiat Clin, Malmo, Sweden
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:240 / 240
页数:1
相关论文
共 50 条
  • [21] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
    Rogers, SL
    Farlow, MR
    Doody, RS
    Mohs, R
    Friedhoff, LT
    Albala, B
    Baumel, B
    Booker, G
    Dexter, J
    Farmer, M
    Feighner, JP
    Ferris, S
    Gordon, B
    Gorman, DG
    Hanna, G
    Harrell, LE
    Hubbard, R
    Kennedy, J
    McCarthy, J
    Scharre, DW
    Schaerf, F
    Schneider, L
    Seltzer, B
    Siegal, A
    Stark, SR
    Strauss, A
    Walshe, TM
    NEUROLOGY, 1998, 50 (01) : 136 - 145
  • [22] Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial
    Henderson, VW
    Paganini-Hill, A
    Miller, BL
    Elble, RJ
    Reyes, PF
    Shoupe, D
    McCleary, CA
    Klein, RA
    Hake, AM
    Farlow, MR
    NEUROLOGY, 2000, 54 (02) : 295 - 301
  • [23] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
    Bae, CY
    Cho, JY
    Cho, KH
    Oho, BH
    Choi, KG
    Lee, HS
    Jung, SP
    Kim, DH
    Choi, KD
    Cho, HS
    Lee, HT
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S2 - S2
  • [24] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
    Bae, CY
    Cho, CY
    Cho, K
    Oh, BH
    Choi, KG
    Lee, HS
    Jung, SP
    Kim, DH
    Lee, S
    Choi, GD
    Cho, H
    Lee, H
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (12) : 1566 - 1571
  • [25] Cognitive impairment networks in Alzheimer's disease: Analysis of three double-blind randomized, placebo-controlled, clinical trials of donepezil
    Rotstein, Anat
    Levine, Stephen Z.
    Samara, Myrto
    Yoshida, Kazufumi
    Goldberg, Yair
    Cipriani, Andrea
    Iwatsubo, Takeshi
    Leucht, Stefan
    Furukawa, Toshiaki A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 57 : 50 - 58
  • [26] Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial
    Bruera, Eduardo
    El Osta, Badi
    Valero, Vicente
    Driver, Larry C.
    Pei, Be-Lian
    Shen, Loren
    Poulter, Valerie A.
    Palmer, J. Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3475 - 3481
  • [27] A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
    Farlow, Martin R.
    Thompson, Richard E.
    Wei, Lee-Jen
    Tuchman, Alan J.
    Grenier, Elaine
    Crockford, David
    Wilke, Susanne
    Benison, Jeffrey
    Alkon, Daniel L.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (02) : 555 - 570
  • [28] Donepezil treatment in Parkinson's disease with dementia: A double-blind, placebo-controlled crossover study
    Aarsland, D
    Larsen, JP
    Janvin, C
    Laake, K
    NEUROLOGY, 2001, 56 (08) : A128 - A128
  • [29] Cerebrolysin - Efficacy and safety in moderate to moderately severe Alzheimer's disease: Subgroup analysis of a randomized, double-blind, placebo-controlled trial
    Moessler, H
    Alvarez, AX
    Cacabelos, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S207 - S207
  • [30] Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial
    Burns, Alistair
    Bemabei, Roberto
    Bullock, Roger
    Cruz Jentoft, Alfonso J.
    Froelich, Lutz
    Hock, Christoph
    Raivio, Minna
    Triou, Eric
    Vandewoude, Maurits
    Wima, Anders
    Came, Elizabeth
    Van Baelen, Bart
    Hammond, Gerry L.
    van Gene, Joop C.
    Schwalen, Susanne
    LANCET NEUROLOGY, 2009, 8 (01): : 39 - 47